Loading the company…
Loading the company…
In the last ten years FDA made 2 decisions for Aventamed Dac (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2025 (1). The latest was on 2025-04-28.
| Family | Decisions on record |
|---|---|
| Ear tubes & middle ear surgery | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-04-28 | 510(k) | K250256 | Solo+ Tympanostomy Tube Device (TTD), Solo+ TTD, Solo+ (Solo+ Tympanostomy Tube Handpiece (Catalogue #: 12115-100-000) and Solo+ Tympanostomy Tube Cartridge (Catalogue #: 12115-200-000)) |
| 2024-05-20 | 510(k) | K232702 | Solo+ Tympanostomy Tube Device (TTD) |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Aventamed Dac.